Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: JACC Heart Fail. 2013;1(1):48–55. doi: 10.1016/j.jchf.2012.10.004

Table 2.

Randomized Therapy and Development of Abnormal Thyroid Function

Randomized Therapy
Amiodarone ICD Placebo
Euthyroid at baseline 639 626 665
Hyperthyroid, new onset 8.0% (51) 2.4% (15) 3.5% (23)
Hypothyroid, new onset 32.9% (210) 9.9% (62) 10.4% (69)
Any abnormal thyroid function, new onset 40.9% (261) 12.3% (77) 13.8% (92)
Relative risk for new-onset abnormal thyroid function,
 vs. placebo
3.65 (2.88–4.63) (p < 0.0001) 0.87 (0.65–1.18) (p = 0.38)
Relative risk for new-onset abnormal thyroid function,
 vs. ICD
4.18 (3.24–5.39) (p < 0.0001)

Values are n, % (n), or hazard ratio (95% confidence interval).

CI = confidence interval; HR = hazard ratio; ICD = implantable cardioverter-defibrillator.